chevron_leftBack
As of 10 June 2026, Heartseed Inc. has a market cap of $261.63M USD, ranking #19393 globally and #1524 in Japan.
It ranks #1745 in the Healthcare sector, and #637 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$261.63MUSD
41.93B JPY
Enterprise Value
$215.83MUSD
34.59B JPY
Revenue (TTM)
$18.89MUSD
3.03B JPY
EBITDA (TTM)
$4.79MUSD
768.26M JPY
Net Income (TTM)
$3.7MUSD
592.5M JPY
EBITDA Margin
25%
Profit Margin
20%
PE Ratio
71.3
PS Ratio
13.9
PB Ratio
5.5
EV/EBITDA
45.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Keiichi Fukuda
open_in_new
Founded
2015
Website
heartseed.jp
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.1% | -4.3% | -1.1% | -8% | 1.8% | -19% |
Upcoming Earnings
Earnings Date
Fri, Jun 12
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
219A
Ｈｅａｒｔｓｅｅｄ株式会社
ISIN: JP3765140003
Shares Out.:
Shares Outstanding:
22.874M1
Shares Float:
12.742M2
|
1,777 JPY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Heartseed Inc.
Heartseed Inc. develops and commercializes iPS cell-derived cardiomyocyte replacement therapy for heart failure. The company’s lead product is HS-001 for heart failure with reduced ejection fraction indications, including dilated cardiomyopathy, old myocardial infraction, and dilated phase of hypertrophic cardiomyopathy. It also develops products using autologous iPSC and HLA knock-out iPSC. In addition, the company offers differentiation induction, mass culture, purification, and myocardial globule production technology. The company was incorporated in 2015 and is headquartered in Tokyo, Japan.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
TSE: 4519
|
$81.54B
31K%
13.07T JPY
|
28.9
|
|
TSE: 4502
|
$52.14B
20K%
8.36T JPY
|
75.1
|
|
TSE: 4578
|
$36.79B
14K%
5.9T JPY
|
15.7
|
|
TSE: 4568
|
$30.33B
11K%
4.86T JPY
|
16.2
|
|
TSE: 4503
|
$25.78B
10K%
4.13T JPY
|
14.2
|
|
TSE: 4507
|
$16.89B
6K%
2.71T JPY
|
13.9
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
291K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
209K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
138K%
|
97.4
|
|
SIX: RO
|
$321.17B
123K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$287.57B
110K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.35B
105K%
218.9B CHF
|
20.5
|
chevron_leftBack